CNR Institutional Research Information System

SARTORIUS, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.476
NA - Nord America 787
EU - Europa 347
SA - Sud America 298
AF - Africa 22
OC - Oceania 6
Totale 2.936
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 738
SG - Singapore 575
CN - Cina 345
BR - Brasile 241
HK - Hong Kong 160
VN - Vietnam 144
IT - Italia 82
FR - Francia 71
KR - Corea 69
JP - Giappone 51
DE - Germania 47
IN - India 34
FI - Finlandia 32
GB - Regno Unito 30
NL - Olanda 25
AR - Argentina 23
CA - Canada 21
BD - Bangladesh 15
MX - Messico 14
ID - Indonesia 11
PL - Polonia 10
ZA - Sudafrica 9
EC - Ecuador 8
IL - Israele 8
IQ - Iraq 8
PK - Pakistan 8
CO - Colombia 7
RU - Federazione Russa 7
SE - Svezia 7
AU - Australia 6
PH - Filippine 6
SA - Arabia Saudita 6
TR - Turchia 6
PY - Paraguay 5
UZ - Uzbekistan 5
ES - Italia 4
KE - Kenya 4
VE - Venezuela 4
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
KZ - Kazakistan 3
MA - Marocco 3
TJ - Tagikistan 3
UA - Ucraina 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
Totale 2.936
Salva come PNG Salva come JPEG
Città #
Singapore 345
Santa Clara 198
Hong Kong 159
Hefei 131
San Jose 120
Beijing 72
Seoul 68
Ashburn 60
Los Angeles 51
Ho Chi Minh City 48
Lauterbourg 45
Tokyo 42
Dallas 35
Hanoi 33
Marigliano 26
New York 25
Helsinki 22
Frankfurt am Main 20
São Paulo 19
Orem 16
Rome 15
Rio de Janeiro 11
Council Bluffs 10
Falkenstein 10
Buffalo 9
Lappeenranta 9
Chennai 8
Da Nang 8
Naples 8
Amsterdam 7
Avellino 7
Minamishinagawa 7
Ninh Bình 7
Warsaw 7
Bengaluru 6
Brasília 6
Denver 6
Düsseldorf 6
Montreal 6
Nuremberg 6
Stockholm 6
Atlanta 5
Haiphong 5
London 5
Manchester 5
Phoenix 5
Portsmouth 5
Salvador 5
Tashkent 5
Ankara 4
Biên Hòa 4
Chicago 4
Dhaka 4
Guarulhos 4
Johannesburg 4
Mexico City 4
Nairobi 4
Santo André 4
Sydney 4
Araçatuba 3
Asunción 3
Baghdad 3
Belo Horizonte 3
Bexley 3
Boardman 3
Bogotá 3
Bologna 3
Boston 3
Brooklyn 3
Buenos Aires 3
Dushanbe 3
Elk Grove Village 3
Goiânia 3
Houston 3
Jackson 3
Jakarta 3
Kunming 3
Lahore 3
Montevideo 3
New Orleans 3
Praia Grande 3
Quito 3
Santiago 3
Vancouver 3
Ahmedabad 2
Algiers 2
Almaty 2
Athens 2
Bandung 2
Barbacena 2
Bauru 2
Bishkek 2
Boynton Beach 2
Brussels 2
Campinas 2
Campo Grande 2
Campos dos Goytacazes 2
Cape Town 2
Carapicuíba 2
Chandigarh 2
Totale 1.887
Salva come PNG Salva come JPEG
Nome #
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells 111
Vectorized delivery of alpha-GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell. 111
Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation 89
Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy 88
Immunostimulatory Phosphatidylmonogalactosyldiacylglycerols (PGDG) from the marine diatom Thalassiosira weissflogii: Inspiration for a novel synthetic toll-like receptor 4 agonist 74
Give a selfie for women @CNR 73
Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants 72
300x100: Protagoniste per la ricerca 71
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants. 70
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies 64
Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking 62
Engineering and Development of a Tissue Model for the Evaluation of Microneedle Penetration Ability, Drug Diffusion, Photothermal Activity, and Ultrasound Imaging: A Promising Surrogate to Ex Vivo and In Vivo Tissues 57
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines 57
Arming filamentous bacteriophage, aNature-made nanoparticles, for new vaccine and immunotherapeutic strategies 56
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. 54
Searching for new vaccine vectors: E2 protein from B. stearothermophilus PDH complex. 53
An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells: Implications for Immunotherapy 53
ImmuNapoli 2019 51
Bioengineered materials with selective antimicrobial toxicity in biomedicine 50
Chitosan decorated cobalt zinc ferrite nanoferrofluid composites for potential cancer hyperthermia therapy: anti-cancer activity, genotoxicity, and immunotoxicity evaluation 50
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies 50
PHAGE CONJUGATES AND USES THEREOF 49
Non-spherical nanostructures in nanomedicine: From noble metal nanorods to transition metal dichalcogenide nanosheets 49
Recombinant filamentous bacteriophages encapsulated in biodegradable polymeric microparticles for stimulation of innate and adaptive immune responses 47
PLGA microparticle formulations for tunable delivery of a nano-engineered filamentous bacteriophage-based vaccine: in vitro and in silico-supported approach 46
Vaccination with Filamentous Bacteriophages trageting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 45
Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205. 45
Cell loaded hydrogel containing Ag-doped bioactive glass-ceramic nanoparticles as skin substitute: Antibacterial properties, immune response, and scarless cutaneous wound regeneration 43
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 43
E2 multimeric scaffold for vaccine formulation: transcriptome analysis of pulsed dendritic cells and immune response by intranasal delivery. 41
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 39
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 39
Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside 39
Filamentous bacteriophage: an antigen and gene delivery system 37
Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems 37
Targeting dendritic cells with filamentous bacteriophage fd carriers displaying anti-Dec 205 scFv bypasses the need of adjuvants 37
Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers 37
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells 34
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFN³ production by CD4+ T cells 33
Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. 33
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2 restricted peptides and to induce strong anti-tumor CTL responses 33
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 33
Nonspherical Metal-Based Nanoarchitectures: Synthesis and Impact of Size, Shape, and Composition on Their Biological Activity 33
Vaccination With Recombinant Filamentous fd Phages Against Parasite Infection Requires TLR 9 Expression 32
TLR-9 dependent dendritic cell activation by filamentous bacteriophage targeting DEC-205. 32
Antigen delivery by using filamentous bacteriophage FD or a macromolecular scaffold derived from a multienzyme complex 32
Filamentous bacteriophages targeting DEC-205 induce dendritic cell maturation and potent T cell response in absence of adjuvants 31
Massive-scale RNA-Sequencing of Bone Marrow derived Dendritic Cells exposed to different antigen display systems. 31
Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells. 30
New recombinant vaccine based on filamentous bacteriophage fd particles targeting DC 29
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 29
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 29
Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex. 28
Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses 28
Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitro and in vivo 28
Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. 28
ImmuNapoli 2016 27
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 27
Co-immunization with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 27
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 26
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 26
Cellular and molecular mechanisms of vaccination by bacteriophages. 26
E2 multimeric scaffolds displaying HIV-1 Envelope regions sustain specific neutralizing antibody and T cell responses when combined with gp160 plasmid DNA 26
Intranasal immunization with E2 multimeric scaffolds displaying the HIV-1 third hypervariable region induces V3-specific IgA antibodies as well as CD4+ T cell responses 26
Comparative analysis of innovative vaccine formulations based on the use of procaryotic display systems. 25
Coimmunizzation with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 22
null 20
Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. 17
Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitro and in vivo. 16
null 14
null 12
null 12
Totale 3.024
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.147
article - articoli 6.058
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 197
Totale 15.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202442 0 0 0 0 0 0 0 1 0 2 34 5
2024/20251.156 1 4 88 28 193 35 9 169 44 46 289 250
2025/20261.826 98 148 197 317 315 112 234 75 109 141 80 0
Totale 3.024